Ryan Hartman
Direttore operativo presso EvoEndo, Inc.
Profilo
Ryan Hartman is currently the Chief Operating Officer at EvoEndo, Inc. He previously worked as the Global Group Director-Marketing & LATAM at Boston Scientific Corp.
from 2017 to 2021.
Mr. Hartman received an undergraduate degree from State University of New York College at New Paltz and a graduate degree from The New School.
Posizioni attive di Ryan Hartman
| Società | Posizione | Inizio |
|---|---|---|
EvoEndo, Inc.
 EvoEndo, Inc. Medical SpecialtiesHealth Technology EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023. | Direttore operativo | 06/04/2023 |
Precedenti posizioni note di Ryan Hartman
| Società | Posizione | Fine |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/05/2021 |
Formazione di Ryan Hartman
| State University of New York College at New Paltz | Undergraduate Degree |
| The New School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
EvoEndo, Inc.
EvoEndo, Inc. Medical SpecialtiesHealth Technology EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Ryan Hartman
